BioCentury
ARTICLE | Clinical News

PTC124 regulatory update

July 11, 2005 7:00 AM UTC

The EMEA granted Orphan Drug designation to PTC124 to treat Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). PTC124 is a small molecule that facilitates complete translation of proteins con...